Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-10-009858
Filing Date
2010-04-05
Accepted
2010-04-05 17:24:58
Documents
1
Period of Report
2010-04-01

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 5655
  Complete submission text file 0001225208-10-009858.txt   7427
Mailing Address 11812 SAN VICENTE BLVD. # 300 LOS ANGELES CA 90049
Business Address
MAYER STEVEN F (Reporting) CIK: 0001280289 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34473 | Film No.: 10732303

Mailing Address P.O. BOX 110526 RESEARCH TRIANGLE PARK NC 27709
Business Address 4101 RESEARCH COMMONS 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 919-316-6300
Talecris Biotherapeutics Holdings Corp. (Issuer) CIK: 0001405197 (see all company filings)

EIN.: 202533768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations